Atlas Trials

Metastatic HER2-Negative Breast Carcinoma

16 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Metastatic HER2-Negative Breast Carcinoma

RecordFirmDate
Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer (NCT05244434)City of Hope Medical Center2022-07-03
Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer (NCT05098210)Fred Hutchinson Cancer Center2022-06-09
Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases (NCT04647916)SWOG Cancer Research Network2021-06-08
Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer (NCT04498520)Pamela Munster2021-03-31
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones (NCT04090398)National Cancer Institute (NCI)2020-08-04
Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer (NCT03939897)National Cancer Institute (NCI)2020-06-17

Track Metastatic HER2-Negative Breast Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.